Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic
Crossref DOI link: https://doi.org/10.1186/s13046-016-0456-2
Published Online: 2016-11-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cerrato, Aniello
Morra, Francesco
Celetti, Angela